Limited Competition for the Continuation of the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Funding Opportunity RFA-DK-18-509 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator of the Coordinating Center (TNCC) that is currently supporting the research being performed by the Type 1 Diabetes TrialNet network. This FOA will support the TNCC in its oversight of the screening of relatives of individuals with type 1 diabetes (T1D) for monitoring and possible inclusion in intervention studies aimed at preservation of insulin-producing cells. The FOA will also support the TNCC in its design, conduct and continu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 10, 2019 Category: Research Source Type: funding

Limited Competition for the Continuation of the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator of the Coordinating Center (TNCC) that is currently supporting the research being performed by the Type 1 Diabetes TrialNet network. This FOA will support the TNCC in its oversight of the screening of relatives of individuals with type 1 diabetes (T1D) for monitoring and possible inclusion in intervention studies aimed at preservation of insulin-producing cells. The FOA will also support the TNCC in its design, conduct and continuation of intervention studies in individuals at early pre-clinical stages of T1D...
Source: NIDDK Funding Opportunities - January 10, 2019 Category: Endocrinology Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-892 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 7, 2018 Category: Research Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-893 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 7, 2018 Category: Research Source Type: funding

Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required)
Funding Opportunity RFA-DK-17-024 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing clinical studies of the use of current and emerging technologies for monitoring of blood glucose and insulin administration in older adults. (aged 65 years or older) Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. This research is intended to improve health, glucose control and quality of l...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 15, 2018 Category: Research Source Type: funding

The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional)
Funding Opportunity RFA-DK-17-031 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research aimed at the characterization and discovery of neoantigens and neoepitopes in type 1 diabetes. These include the characterization of the humoral and cell mediated autoimmune responses elicited by these neoepitopes and neoantigens and their role in the etiology and pathophysiology of type 1 diabetes. These studies should be integrated with the present knowledge of established epitopes and antigens (e.g. autoantibodies f...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 15, 2018 Category: Research Source Type: funding

The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research aimed at the characterization and discovery of neoantigens and neoepitopes in type 1 diabetes. These include the characterization of the humoral and cell mediated autoimmune responses elicited by these neoepitopes and neoantigens and their role in the etiology and pathophysiology of type 1 diabetes. These studies should be integrated with the present knowledge of established epitopes and antigens (e.g. autoantibodies for insulin, GAD65, IA-2, and ZnT8T).Salvatore Sechi, Ph.D. | RFA-DK-17-031 (Sour...
Source: NIDDK Funding Opportunities - February 15, 2018 Category: Endocrinology Source Type: funding

Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required)
This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing clinical studies of the use of current and emerging technologies for monitoring of blood glucose and insulin administration in older adults. (aged 65 years or older) Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. This research is intended to improve health, glucose control and quality of life of older patients with type 1 diabetes Only human studies will be considered...
Source: NIDDK Funding Opportunities - February 15, 2018 Category: Endocrinology Source Type: funding

The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research aimed at the characterization and discovery of neoantigens and neoepitopes in type 1 diabetes. These include the characterization of the humoral and cell mediated autoimmune responses elicited by these neoepitopes and neoantigens and their role in the etiology and pathophysiology of type 1 diabetes. These studies should be integrated with the present knowledge of established epitopes and antigens (e.g. autoantibodies for insulin, GAD65, IA-2, and ZnT8T).Salvatore Sechi, Ph.D. | RFA-DK-17-031 (Sour...
Source: NIDDK Funding Opportunities - February 15, 2018 Category: Endocrinology Source Type: funding

Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required)
This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing clinical studies of the use of current and emerging technologies for monitoring of blood glucose and insulin administration in older adults. (aged 65 years or older) Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. This research is intended to improve health, glucose control and quality of life of older patients with type 1 diabetes Only human studies will be considered...
Source: NIDDK Funding Opportunities - February 15, 2018 Category: Endocrinology Source Type: funding

Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-17-020 from the NIH Guide for Grants and Contracts. Type 1 diabetes (T1D) results in part from the autoimmune-mediated dysfunction or destruction of insulin-producing pancreatic beta cells. This funding opportunity is for projects that seek to discover ways to change the course of the disease by directly establishing tolerance. Immune responses could be engineered for tolerance induction through the manipulation of antigens, cells, or cellular microenvironments. Collaborations between T1D experts and investigators from other fields, including (but not limited to) cancer immunology and biomateria...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2018 Category: Research Source Type: funding

Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes Research (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-17-019 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing the development of targeted mass spectrometric assays (e.g. Multiple Reaction Monitoring) for proteins and peptides of primary interest to the type 1 diabetes research community (e.g. glucagon, somatostatin, C-peptide, insulin). The proposed assays should be highly reproducible, easily transferable to other laboratories, easy to multiplex, and validated in human plasma or serum. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2018 Category: Research Source Type: funding

Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes Research (U01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing the development of targeted mass spectrometric assays (e.g. Multiple Reaction Monitoring) for proteins and peptides of primary interest to the type 1 diabetes research community (e.g. glucagon, somatostatin, C-peptide, insulin). The proposed assays should be highly reproducible, easily transferable to other laboratories, easy to multiplex, and validated in human plasma or serum.Salvatore Sechi, Ph.D. | RFA-DK-17-019 (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - February 14, 2018 Category: Endocrinology Source Type: funding

Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
Type 1 diabetes (T1D) results in part from the autoimmune-mediated dysfunction or destruction of insulin-producing pancreatic beta cells. This funding opportunity is for projects that seek to discover ways to change the course of the disease by directly establishing tolerance. Immune responses could be engineered for tolerance induction through the manipulation of antigens, cells, or cellular microenvironments. Collaborations between T1D experts and investigators from other fields, including (but not limited to) cancer immunology and biomaterials engineering, are especially encouraged.Lisa Spain, Ph.D. | RFA-DK-17-020 (Sou...
Source: NIDDK Funding Opportunities - February 14, 2018 Category: Endocrinology Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-016 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2017 Category: Research Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2017 Category: Research Source Type: funding

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
Funding Opportunity RFA-DK-17-507 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator of the Data Coordinating Center (DCC) that is currently supporting the research being performed by the complex and effective Type 1 Diabetes TrialNet network. This FOA will support the design and conduct of new-onset trials (as selected by the TrialNet Steering Committee) aimed at preservation of insulin-producing cells in individuals with new-onset diabetes. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2017 Category: Research Source Type: funding

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator of the Data Coordinating Center (DCC) that is currently supporting the research being performed by the complex and effective Type 1 Diabetes TrialNet network. This FOA will support the design and conduct of new-onset trials (as selected by the TrialNet Steering Committee) aimed at preservation of insulin-producing cells in individuals with new-onset diabetes. (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - April 21, 2017 Category: Endocrinology Source Type: funding

Validation of survey questions to distinguish type 1 and type 2 diabetes among adults with diabetes
Funding Opportunity ID: 288978 Opportunity Number: RFA-DP-17-002 Opportunity Title: Validation of survey questions to distinguish type 1 and type 2 diabetes among adults with diabetesOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.068Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federall...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
Funding Opportunity ID: 290497 Opportunity Number: RFA-DK-16-505 Opportunity Title: Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: Food and NutritionHealthCategory Explanation: CFDA Number(s): 93.84793.85593.856Eligible Applicants: Public and State controlled institutions of higher educationAdditional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not ...
Source: Grants.gov - December 6, 2016 Category: Research Tags: Food and Nutrition Health Source Type: funding

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
Funding Opportunity RFA-DK-16-505 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator of the Data Coordinating Center (DCC) that is currently supporting the research being performed by the complex and effective Type 1 Diabetes TrialNet network. This FOA will support the design and conduct of new-onset trials (as selected by the TrialNet Steering Committee) aimed at preservation of insulin-producing cells in individuals with new-onset diabetes. The DCC will support a wide range of research projects in varying stage...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 5, 2016 Category: Research Source Type: funding

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator of the Data Coordinating Center (DCC) that is currently supporting the research being performed by the complex and effective Type 1 Diabetes TrialNet network. This FOA will support the design and conduct of new-onset trials (as selected by the TrialNet Steering Committee) aimed at preservation of insulin-producing cells in individuals with new-onset diabetes. The DCC will support a wide range of research projects in varying stages of development, implementation and completion. The DCC will provide for data an...
Source: NIDDK Funding Opportunities - December 5, 2016 Category: Endocrinology Source Type: funding

Validation of survey questions to distinguish type 1 and type 2 diabetes among adults with diabetes
Opportunity ID: 288978 Opportunity Number: RFA-DP-17-002 Opportunity Title: Validation of survey questions to distinguish type 1 and type 2 diabetes among adults with diabetesOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.068Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recogn...
Source: Grants.gov - September 19, 2016 Category: Research Tags: Health Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21)
Funding Opportunity Number: PAR-16-123 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.39393.399Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IR...
Source: Grants.gov - March 9, 2016 Category: Research Tags: Education Health Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01)
Funding Opportunity Number: PAR-16-122 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.39393.399Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IR...
Source: Grants.gov - March 9, 2016 Category: Research Tags: Education Health Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01)
Funding Opportunity PAR-16-122 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by prev...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 9, 2016 Category: Research Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21)
Funding Opportunity PAR-16-123 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by prev...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 9, 2016 Category: Research Source Type: funding

Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (DP3)
Funding Opportunity Number: RFA-DK-15-028 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with ...
Source: Grants.gov - September 25, 2015 Category: Research Tags: Food and Nutrition Health Source Type: funding

Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (DP3)
Funding Opportunity RFA-DK-15-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing clinical studies of the use of current and emerging technologies for monitoring of blood glucose and insulin administration in older adults with T1D.Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population.This research is intended to improve health, glucose control and quality of life of older pat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 24, 2015 Category: Research Source Type: funding

Physical activity and weight control interventions among cancer survivors: Effects on biomarkers of prognosis and survival (R21)
Funding Opportunity Number: PAR-12-229 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.39393.399Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IR...
Source: Grants.gov - July 25, 2015 Category: Research Tags: Education Health Source Type: funding

Physical activity and weight control interventions among cancer survivors: Effects on biomarkers of prognosis and survival (R01)
Funding Opportunity Number: PAR-12-228 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.39393.399Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IR...
Source: Grants.gov - July 25, 2015 Category: Research Tags: Education Health Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21)
Funding Opportunity Number: PA-15-310 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.39393.399Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS...
Source: Grants.gov - July 25, 2015 Category: Research Tags: Education Health Source Type: funding

Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring (R43/R44)
Funding Opportunity Number: RFA-DK-15-022 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Nov 18, 2015Award Ceiling: Expected Number of Awards: Creation Date: Jul 24, 2015Funding Opportunity Description: This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of innovative technologies that may advance progress toward integrated long ...
Source: Grants.gov - July 25, 2015 Category: Research Tags: Food and Nutrition Health Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01)
Funding Opportunity Number: PA-15-311 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.39393.399Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS...
Source: Grants.gov - July 25, 2015 Category: Research Tags: Education Health Source Type: funding

Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring (R43/R44)
Funding Opportunity RFA-DK-15-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of innovative technologies that may advance progress toward integrated long term glucose regulated insulin/pancreatic hormones automated delivery systems (artificial pancreas). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2015 Category: Research Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01)
Funding Opportunity PA-15-311 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2015 Category: Research Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21)
Funding Opportunity PA-15-310 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2015 Category: Research Source Type: funding

The JDRF and the Helmsley Charitable Trust Request Expressions of Interest for Improved Assays for Predicting Risk for T1D
JDRF and The Leona M. and Harry B. Helmlsey Charitable Trust are soliciting expressions of interest (EOI) for optimizing and validating existing technologies for predictive screening for T1D risk and autoimmunity to be applied for wide-spread use in population-based screening efforts, including newborn or childhood based screening. EOIs requesting development of new assays will not be considered. BACKGROUND Prevention of type 1 diabetes (T1D) represents a “cure” for those at-risk of developing the disease, and, in fact, will likely represent the most cost-effective approach to a cure and is becoming incr...
Source: ScanGrants feed - September 10, 2014 Category: Research Authors: JDRF/Helmsley Charitable Trust Source Type: funding

JDRF Requests Expressions of Interest for Studies Relevant to the Discovery and Development of Antigen Specific Therapies for Human Type 1 Diabetes
Key Dates: August 15, 2014: Expressions of interest (EOI) release date October 10, 2014: EOI due date October 31, 2014: EOI decision notification December 10, 2014: Full application due date (for accepted EOIs) April 2015: Award notification May 2015: Earliest start date Purpose of Request JDRF is soliciting expressions of interest (EOI) for the discovery, development, pre-clinical or pilot clinical testing of novel antigen-specific therapeutic approaches designed to induce durable immunoregulation for human type 1 diabetes (T1D). JDRF is committed to translation of research findings towards clinical resul...
Source: ScanGrants feed - September 10, 2014 Category: Research Authors: JDRF Source Type: funding

Request for Expressions of Interest: Exploratory Clinical Trials of Non-insulin Adjunct Therapies in Type 1 Diabetes
Expression of Interest Deadline: July 11, 2014 JDRF, the world’s leading non-profit organization with the mission to cure, treat and prevent type 1 diabetes (T1D), invites Expressions of Interest (EOI) for clinical trials to evaluate non-insulin based adjunct therapies for improved glycemic and overall metabolic control of T1D. JDRF has an unprecedented opportunity to make progress in the clinical assessment of adjunctive therapies for T1D that move beyond an insulin-centric view of the disease. At present, several agents–mostly approved T2D therapies such as incretins, SGLT inhibitors, metformin&ndash...
Source: ScanGrants feed - May 27, 2014 Category: Research Authors: JDRF Source Type: funding

Request for Letters of Intent: Glucose Responsive Insulin Discovery and Validation
Letter of Interest Deadline: July 11, 2014 JDRF, the world’s leading non-profit organization with the mission to cure, treat and prevent type 1 diabetes (T1D), invites Letters of Intent (LOI) for the discovery and validation of novel glucose responsive insulin (GRI) drugs for better treatment of insulin-dependent diabetes mellitus (IDDM) and reducing the burden of daily management of the disease, particularly T1D. Proposals (supported by strong rationale and/or preliminary data) will be considered for a maximum budget of up to $500,000* per year for up to 3 years of funding (including 10% indirect costs) ...
Source: ScanGrants feed - May 27, 2014 Category: Research Authors: JDRF Source Type: funding

Call for Nominations: Banting Medal for Scientific Achievement Award
Banting Medal for Scientific Achievement Award The Banting Medal for Scientific Achievement Award is the highest scientific award of the American Diabetes Association. Given in memory of Sir Frederick Banting, a medical scientist, doctor and Nobel laureate who is noted as one of the key investigators in the discovery of insulin, the Banting Medal is awarded annually to honor highly meritorious career achievement in the field of diabetes research. Criteria for Selection: Nominee will have demonstrated significant, long-term contribution to the understanding of diabetes, its treatment and/or prevention. Publications a...
Source: ScanGrants feed - May 21, 2014 Category: Research Authors: American Diabetes Association Source Type: funding

Request for Proposals: Automated Insulin Delivery Initiative
LOI Submission Deadline: January 15, 2014 Over the past decade, advances in medical device technology have had significant impact on monitoring, management and treatment of type 1 diabetes (T1D). However, data from the T1D Exchange demonstrates that T1D is still not a safe or well-managed disease, despite using today’s tools.  Thus, the goal of the Automated Insulin Delivery Initiative (AIDI) of The Leona M. and Harry B. Helmsley Charitable Trust (HCT) Type 1 Diabetes (T1D) Program is to accelerate the development and regulatory approval of automated insulin delivery systems to improve the management and ca...
Source: ScanGrants feed - December 31, 2013 Category: Research Authors: Leona M. and Harry B. Helmsley Charitable Trust Source Type: funding

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D): Towards an Artificial Pancreas (SBIR) (R43/R44)
Funding Opportunity Number: RFA-DK-13-028 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Mar 14, 2014Award Ceiling: Expected Number of Awards: Creation Date: Dec 04, 2013Funding Opportunity Description: This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may adva...
Source: Grants.gov - December 4, 2013 Category: Research Tags: Food and Nutrition Health Source Type: funding

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D): Towards an Artificial Pancreas (SBIR) (R43/R44)
Funding Opportunity RFA-DK-13-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward integrated long term glucose regulated insulin/pancreatic hormones delivery systems (artificial pancreas). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2013 Category: Research Source Type: funding

Call for Nominations: American Diabetes Association 2014 Banting Medal for Scientific Achievement Award
Deadline: October 18, 2013 The Banting Medal for Scientific Achievement Award is the highest scientific award of the American Diabetes Association. Given in memory of Sir Frederick Banting, a medical scientist, doctor and Nobel laureate who is noted as one of the key investigators in the discovery of insulin, the Banting Medal is awarded annually to honor highly meritorious career achievement in the field of diabetes research. Criteria for Selection: • Nominee will have demonstrated significant, long-term contribution to the understanding of diabetes, its treatment and/or prevention. • Publications and...
Source: ScanGrants feed - July 22, 2013 Category: Research Authors: American Diabetes Association Source Type: funding

Request for Proposals: Creative Computational Approaches to Accelerate Drug Discovery for the Treatment and Prevention of Dementia
Current methods of drug discovery have had limited success at predicting clinical efficacy of investigational therapies in patients with Alzheimer’s disease and other age-related dementias. Computational modeling, systems biology and pharmacology, and translational bioinformatics represent a tremendous yet relatively under-developed opportunity to accelerate and improve this process particularly for dementias. The Alzheimer’s Drug Discovery Foundation (ADDF) program on Aging & Alzheimer’s Disease Prevention is requesting proposals for innovative computational approaches to map disease and pred...
Source: ScanGrants feed - June 4, 2013 Category: Research Authors: Alzheimer’s Drug Discovery Foundation Source Type: funding

JDRF Requests Expressions of Interest for Studies Relevant to the Discovery and Development of Antigen Specific Therapies for Human Type 1 Diabetes
Key Dates: February 13, 2013: Expressions of interest (EOI) due date (EOIs must be submitted via the proposalCentral website: https://proposalcentral.altum.com) March 8, 2013: EOI decision notification April 15, 2013: Full application due date (for accepted EOIs) July 2013: Award notification Purpose of Request JDRF is soliciting expressions of interest (EOI) for the discovery, development, pre-clinical or pilot clinical testing of novel antigen-specific therapeutic approaches designed to induce durable immunoregulation for human type 1 diabetes (T1D). JDRF is committed to translation of research findings ...
Source: ScanGrants feed - January 30, 2013 Category: Research Authors: JDRF Source Type: funding